Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring ...

Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 ...

The updated guidelines recommend SGLT2 inhibitors as first-line therapy for many cats with diabetes and detail patient selection, β-hydroxybutyrate monitoring, diet, and when to switch to insulin. "My ...

Times of San Diego reviewed hundreds of medical records from inside the Otay Mesa detention center.

Millions of adults are living with blood sugar levels high enough to cause damage, yet low enough to fly under the radar of ...

Dr. Monty Pal introduces the program by outlining the evolving treatment landscape for advanced renal cell carcinoma (RCC) ...

Treatment sequencing in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains a major unmet clinical need ...

A new collaborative study reports the discovery and application of a novel therapeutic strategy to selectively target EGFR ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update The ...

A Korean target trial emulation found that starting antidiabetic medication within 12 months of newly crossing type 2 ...

The FDA has approved sacituzumab govitecan-hziy as first-line therapy for adults with unresectable locally advanced or ...